Metabolic Bone Diseases and Osteoporosis

Metabolic bone diseases encompass a group of disorders characterized by abnormalities in bone metabolism, leading to decreased bone density and increased fracture risk. Osteoporosis, the most common metabolic bone disease, results from an imbalance between bone formation and resorption, often exacerbated by hormonal changes, nutritional deficiencies, or aging. Management strategies focus on optimizing bone health through lifestyle modifications, pharmacotherapy, and fracture prevention strategies. Research efforts aim to unravel the complex pathophysiology of bone diseases and develop targeted therapies to mitigate skeletal fragility and reduce the burden of osteoporotic fractures.

    Related Conference of Metabolic Bone Diseases and Osteoporosis

    September 25-26, 2024

    5th World Summit on Diabetes Expo

    Rome, Italy
    October 14-15, 2024

    3rd International Summit on Hormonal Disorders

    Madrid, Spain
    November 13-14, 2024

    33rd International Diabetes and Healthcare Conference

    Paris, France
    November 22-23, 2024

    20th World Congress on Endocrinology & Diabetes

    Amsterdam, Netherlands
    November 27-28, 2024

    7th Annual Meeting on Diabetes and Endocrinology

    Paris, France
    November 27-28, 2024

    14th World Congress on Endocrinology and Diabetes

    Aix-en-Provence, France
    February 24-25, 2025

    34th European Diabetes Congress

    London, UK
    March 17-18, 2025

    5th European Endocrinology and Diabetes Congress

    Paris, France
    April 10-11, 2025

    5th World Congress on Endocrine and Diabetes

    Dubai, UAE
    May 19-20, 2025

    6th World Summit on Diabetes

    Rome, Italy

    Metabolic Bone Diseases and Osteoporosis Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in